Pessis Rachel, Lantieri Laurent, Britto Jonathan A, Leguerinel Caroline, Wolkenstein Pierre, Hivelin Mikaël
Department of Plastic Surgery, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (APHP), PRES Sorbonne Paris Cité, Université Paris Descartes, Paris, France.
Department of Plastic Surgery, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (APHP), PRES Sorbonne Paris Cité, Université Paris Descartes, Paris, France; Neurofibromatosis National Reference Center, France.
J Craniomaxillofac Surg. 2015 Oct;43(8):1684-93. doi: 10.1016/j.jcms.2015.06.023. Epub 2015 Jun 27.
Patients with orbito-temporal neurofibromatosis (OTNF) bear a heavy burden of surgical care. We studied 47 consecutive patients with OTNF from the French Neurofibromatosis 1 Referral Center cohort (n > 900), over a 15-year period to determine the clinical features most likely to predict repeat surgery and longer duration of surgical care. Forty-seven patients (5.2% of the NF1 patients' cohort) underwent 79 procedures with a 4.8 years average follow-up. Soft-tissue surgery had a high revision rate (19/45 patients), skeletal surgery did not (2/13 patients). Transosseous wire canthopexy and facial aesthetic unit remodeling were associated with stable outcome. Ptosis repair carried an unfavorable outcome, particularly in the presence of sphenoid dysplasia. Stable skeletal remodeling was achieved with polyethylene implants and/or cementoplasty. Multiple procedures were undertaken in 70% of patients and were predicted by the NF volume, canthopexy, skeletal dysplasia, or a Jackson's classification 2 and/or 3; but not by declining visual acuity. A classification based upon predictive risk of repeated procedures is proposed: Group 1: Isolated soft tissue infiltration not requiring levator palpebrae or canthal surgery; Group 2: Soft tissue involvement requiring ptosis repair or canthopexy, or NF great axis over 4.5 cm; Group 3: Presence of sphenoid dysplasia with pulsatile proptosis, regardless of visual acuity.
眶颞部神经纤维瘤病(OTNF)患者承受着沉重的手术治疗负担。我们对法国神经纤维瘤病1转诊中心队列(n>900)中连续47例OTNF患者进行了为期15年的研究,以确定最有可能预测再次手术和更长手术治疗时间的临床特征。47例患者(占NF1患者队列的5.2%)接受了79次手术,平均随访4.8年。软组织手术的翻修率较高(45例患者中有19例),骨骼手术则不然(13例患者中有2例)。经骨钢丝内眦固定术和面部美学单元重塑的效果稳定。上睑下垂修复的效果不佳,尤其是在存在蝶骨发育异常的情况下。使用聚乙烯植入物和/或骨水泥成形术可实现稳定的骨骼重塑。70%的患者接受了多次手术,可通过神经纤维瘤体积、内眦固定术、骨骼发育异常或杰克逊分类2级和/或3级预测;但不能通过视力下降来预测。我们提出了一种基于重复手术预测风险的分类方法:第1组:孤立的软组织浸润,不需要提上睑肌或内眦手术;第2组:需要上睑下垂修复或内眦固定术的软组织受累,或神经纤维瘤长轴超过4.5 cm;第3组:存在伴有搏动性眼球突出的蝶骨发育异常,无论视力如何。